نتایج جستجو برای: autoimmune lymphoproliferative synd

تعداد نتایج: 67222  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1974
M J Dauphinee N Talal A L Goldstein A White

New Zealand Black (NZB) mice develop after 16 weeks of age an autoimmune and lymphoproliferative disease which is a model for systemic lupus erythematosus and lymphoid malignancy in humans. At this age, the mice manifest a progressive decline in T lymphocyte (thymus-derived lymphocyte) functions and serum thymosin levels. Thymocytes from 8-week old NZB mice exhibit an abnormal DNA synthetic res...

Journal: :Clinical and experimental rheumatology 2003
V Pittoni M Sorice A Circella R Cangemi L Conti U Ramenghi G M Gandolfo U Dianzani G Valesini

OBJECTIVE A human lymphoproliferative syndrome characterized by a defect of the Fas-mediated apoptosis pathway in the absence of a fas gene mutation (Autoimmune Lymphoproliferative Disease) has recently been described and characterized by autoimmune phenomena. The aim of this study was to investigate the presence of antinuclear and antiphospholipid antibodies and to define their specificity in ...

Journal: :Blood 1997
U Dianzani M Bragardo D DiFranco C Alliaudi P Scagni D Buonfiglio V Redoglia S Bonissoni A Correra I Dianzani U Ramenghi

Fas (CD95) is a transmembrane molecule that induces programmed cell death (PCD) of lymphocytes. We examined its function in children with chronic thrombocytopenia, serum autoantibodies, and lymphadenopathy and/or splenomegaly. We found that T-cell lines from six of seven patients with this autoimmune/lymphoproliferative disease (ALD) were relatively resistant to PCD induced by monoclonal antibo...

2014
Janice E. Ma Jerry D. Brewer

Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy. The infectivity of Merkel cell polyomavirus (MCPyV), an apparent agent in MCC development, may be exacerbated with impaired immune responses. This paper reviews relevant data regarding the role of immunosuppression in the development of MCC and describes modes of immunodeficient states. Because of the inherently low inci...

2013
Maurizio Aricò Elena Boggio Valentina Cetica Matteo Melensi Elisabetta Orilieri Nausicaa Clemente Giuseppe Cappellano Sara Buttini Maria Felicia Soluri Cristoforo Comi Carlo Dufour Daniela Pende Irma Dianzani Steven R. Ellis Sara Pagliano Stefania Marcenaro Ugo Ramenghi Annalisa Chiocchetti Umberto Dianzani

Autoimmune lymphoproliferative syndrome (ALPS) is caused by genetic defects decreasing Fas function and is characterized by lymphadenopathy/splenomegaly and expansion of CD4/CD8 double-negative T cells. This latter expansion is absent in the ALPS variant named Dianzani Autoimmune/lymphoproliferative Disease (DALD). In addition to the causative mutations, the genetic background influences ALPS a...

Journal: :The Journal of Experimental Medicine 2002
Megan S. Ford Kevin J. Young Zhuxu Zhang Pamela S. Ohashi Li Zhang

Lymphoproliferative (lpr) mice, which lack functional Fas receptor expression and develop autoimmune lymphoproliferative disease, have an accumulation of T cell receptor-alphabeta(+)CD4(-)CD8(-) (double negative T cells [DNTC]) in the periphery. The function of the accumulating DNTC is not clear. In this study we demonstrate that B6/lpr DNTC can dose dependently kill syngeneic CD8(+) and CD4(+)...

2015
V. Koneti Rao

Autoimmune lymphoproliferative syndrome (ALPS) is a rare disorder of apoptosis. It is frequently caused by mutations in FAS (TNFRSF6) gene. Unlike most of the self-limiting autoimmune cytopenias sporadically seen in childhood, multi lineage cytopenias due to ALPS are often refractory, as their inherited genetic defect is not going to go away. Historically, more ALPS patients have died due to ov...

Journal: :Blood 2009
Marc Michel Valérie Chanet Agnès Dechartres Anne-Sophie Morin Jean-Charles Piette Lorenzo Cirasino Giovanni Emilia Francesco Zaja Marco Ruggeri Emmanuel Andrès Philippe Bierling Bertrand Godeau Francesco Rodeghiero

Evans syndrome (ES) is a rare disease characterized by the simultaneous or sequential development of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) and/or immune neutropenia. To better describe the characteristics and outcome of ES in adults, a survey was initiated in 2005. The data from 68 patients (60% of them women) fulfilling strict inclusion criteria for ES are report...

Journal: :Pediatrics 2013
Elena Boggio Maurizio Aricò Matteo Melensi Irma Dianzani Ugo Ramenghi Umberto Dianzani Annalisa Chiocchetti

This article presents a case report for a child presenting with mixed clinical features of autoimmune lymphoproliferative syndrome (ALPS), familial hemophagocytic lymphohistiocytosis (FHL), and X-linked lymphoproliferative (XLP) disease. From 6 months, he exhibited splenomegaly and lymphoadenopathy and from 4 years, he showed recurrent severe autoimmune hemocytopenia and sepsislike bouts of fev...

Journal: :Hematology. American Society of Hematology. Education Program 2006
Philip C Hoffman

Autoimmune hemolytic anemia (AIHA) is most often idiopathic. However, in recent years, AIHA has been noted with increased incidence in patients receiving purine nucleoside analogues for hematologic malignancies; it has also been described as a complication of blood transfusion in patients who have also had alloimmunization. As the technology of hematopoietic stem cell transplantation has become...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید